|
1
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I: EUROCARE-4 Working
Group: Recent cancer survival in Europe: A 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Natsuizaka M, Omura T, Akaike T, Kuwata Y,
Yamazaki K, Sato T, Karino Y, Toyota J, Suga T and Asaka M:
Clinical features of hepatocellular carcinoma with extrahepatic
metastases. J Gastroenterol Hepatol. 20:1781–1787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ueno N, Kanamaru T, Kawaguchi K, Tanaka K,
Inoue K, Idei Y and Yamamoto M: A hepatocellular carcinoma with
lymph node metastasis and invasion into the gallbladder:
Preoperative difficulty ruling out a gallbladder carcinoma. Oncol
Rep. 8:331–335. 2001.PubMed/NCBI
|
|
4
|
Texler ML, Pierides J and Maddern GJ: Case
report: A hepatocellular carcinoma metastasis in the distal
pancreas. J Gastroenterol Hepatol. 13:467–470. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hyun YS, Choi HS, Bae JH, Jun DW, Lee HL,
Lee OY, Yoon BC, Lee MH, Lee DH, Kee CS, et al: Chest wall
metastasis from unknown primary site of hepatocellular carcinoma.
World J Gastroenterol. 12:2139–2142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tearda T and Sugiura M: Metastatic
hepatocellular carcinoma of the skin diagnosed with hepatocyte
paraffin 1 and α-fetoprotein immunostainings. Int J Surg Pathol.
18:433–436. 2010.PubMed/NCBI
|
|
7
|
Terada T and Maruo H: Unusual extrahepatic
metastatic sites from hepatocellular carcinoma. Int J Clin Exp
Pathol. 6:816–820. 2013.PubMed/NCBI
|
|
8
|
Camus M, Tosolini M, Mlecnik B, Pagès F,
Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval
P, et al: Coordination of intratumoral immune reaction and human
colorectal cancer recurrence. Cancer Res. 69:2685–2693. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Möller PI, von Reyher U, Leithäuser F and
Sträter J: CD95 (APO-1/Fas) and CD95-ligand (CD95L). Implications
of these apoptosis mediating receptor/ligand systems in the
pathogenesis of autoimmune diseases. Verh Dtsch Ges Pathol.
80:12–20. 1996.(In German). PubMed/NCBI
|
|
10
|
Türbachova I, Schwachula T, Vasconcelos I,
Mustea A, Baldinger T, Jones KA, Bujard H, Olek A, Olek K, Gellhaus
K, et al: The cellular ratio of immune tolerance (immunoCRIT) is a
definite marker for aggressiveness of solid tumors and may explain
tumor dissemination patterns. Epigenetics. 8:1226–1235. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rutherford AE, Hynan LS, Borges CB,
Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A,
Harrison E, et al: Serum apoptosis markers in acute liver failure:
A pilot study. Clin Gastroenterol Hepatol. 5:1477–1483. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bosman FT: World Health Organization
(WHO); International Agency for Research on Cancer (IARC): WHO
classification of tumours of the digestive system (4th). IARC
Press. Lyon, France: 212–216. 2010.
|
|
13
|
Kolokythas A, Weiskopf S, Singh M and
Cabay RJ: Renal Cell Carcinoma: Delayed Metachronous Metastases to
Parotid and Cerebellum. J Oral Maxillofac Surg. 73:1296–1303. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Campoli PM, Ejima FH, Cardoso DM, Silva
OQ, Filho Santana JB, Queiroz Barreto PA, Machado MM, Mota ED,
Araujo Filho JA, Alencar Rde C and Mota OM: Metastatic cancer to
the stomach. Gastric Cancer. 9:19–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Amicucci G, Sozio ML, Sozio A and Rizzo
FM: Gastric metastases of breast carcinoma. Am J Gastroenterol.
94:8591999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oda Kondo H, Yamao T, Saito D, Ono H,
Gotoda T, Yamaguchi H, Yoshida S and Shimoda T: Metastatic tumors
to the stomach: Analysis of 54 patients diagnosed at endoscopy and
347 autopsy cases. Endoscopy. 33:507–510. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gopalan S, Bose JC and Periasamy S:
Anastomotic Recurrence of Colon Cancer-is it a Local Recurrence, a
Second Primary, or a Metastatic Disease (Local Manifestation of
Systemic Disease)? Indian J Surg. 77:232–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Menuck LS and Amberg JR: Metastatic
disease involving the stomach. Am J Dig Dis. 20:903–913. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung HJ, Lee HY, Kim BW, Jung SM, Kim HG,
Ji JS, Choi H and Lee BI: Gastic metastasis from ovarian
adenocarcinoma presenting as a submucosal tumor without ulceration.
Gut Liver. 3:211–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mellman I, Coukos G and Dranoff G: Cancer
immunotherapy comes of age. Nature. 480:480–489. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaplan DH, Shankaran V, Dighe AS, Stockert
E, Aguet M, Old LJ and Schreiber RD: Demonstration of an interferon
gamma-dependent tumor surveillance system in immunocompetent mice.
Proc Natl Acad Sci USA. 95:7556–7561. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Campoli M, Ferrone S, Zea AH, Rodriguez PC
and Ochoa AC: Mechanisms of tumor evasion. Cancer Treat Res.
123:61–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun AM, Li CG, Zhang YQ, Lin SM, Niu HR
and Shi YS: Hepatocarcinoma cell-derived hepatoma-derived growth
factor (HDGF) induces regulatory T cells. Cytokine. 72:31–35. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gordon N and Kleinerman ES: The role of
Fas/FasL in the metastatic potential of osteosarcoma and targeting
this pathway for the treatment of osteosarcoma lung metastases.
Cancer Treat Res. 152:497–508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pezzano M, Samms M and Guyden JC: TNF and
Fas-induced apoptosis during negative selection in thymic nurse
cells. Ethn Dis. 11:154–156. 2001.PubMed/NCBI
|
|
26
|
He D, Xiao L, Chen JN, Liang Q and Shao
CK: Correlation of Fas/FasL expression to cell apoptosis in
Epstein-Barr virus-associated gastric carcinoma. Chin J Cancer.
29:283–287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
O'Connell J, O'Sullivan GC, Collins JK and
Shanahan F: The Fas counterattack: Fas-mediated T cell killing by
colon cancer cells expressing Fas ligand. J Exp Med. 184:1075–1082.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Strand S and Galle PR: Immune evasion by
tumours: Involvement of the CD95 (APO-1/Fas) system and its
clinical implications. Mol Med Today. 4:63–68. 1998. View Article : Google Scholar : PubMed/NCBI
|
